Literature DB >> 2900979

Direct detection of HIV RNA expression in seropositive subjects.

C Hart1, G Schochetman, T Spira, A Lifson, J Moore, J Galphin, J Sninsky, C Y Ou.   

Abstract

The polymerase chain reaction (PCR) and reverse transcription were used to assess human immunodeficiency virus type 1 (HIV1) RNA expression in peripheral blood mononuclear cell samples from seropositive subjects. HIV RNA was detected from seropositive subjects who had no symptoms, lymphadenopathy syndrome, and acquired immunodeficiency syndrome. DNA PCR of the samples used for RNA extraction showed that seventeen of eighteen (94%) contained HIV proviral DNA. Eleven (65%) of the seventeen DNA-positive samples were also positive for HIV RNA, including samples from four patients undergoing antiviral drug treatment. Serum HIV antigen assays detected only six (32%) of the nineteen PCR-positive samples. Owing to the speed and high sensitivity of PCR for HIV detection, this technique will be suitable for monitoring antiviral therapy and the virus load of people with HIV infections.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2900979     DOI: 10.1016/s0140-6736(88)90639-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  41 in total

1.  Reverse transcriptase inhibits Taq polymerase activity.

Authors:  L N Sellner; R J Coelen; J S Mackenzie
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

Review 2.  [Polymerase chain reaction: an overview].

Authors:  U Linz; H Degenhardt
Journal:  Naturwissenschaften       Date:  1990-11

Review 3.  The polymerase chain reaction.

Authors:  I Peake
Journal:  J Clin Pathol       Date:  1989-07       Impact factor: 3.411

4.  Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction.

Authors:  S Menzo; P Bagnarelli; M Giacca; A Manzin; P E Varaldo; M Clementi
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

5.  Reduction in plasma human immunodeficiency virus ribonucleic acid after dideoxynucleoside therapy as determined by the polymerase chain reaction.

Authors:  M Holodniy; D A Katzenstein; D M Israelski; T C Merigan
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

6.  Comparison of three nonradioisotopic polymerase chain reaction-based methods for detection of human immunodeficiency virus type 1.

Authors:  A J Whetsell; J B Drew; G Milman; R Hoff; E A Dragon; K Adler; J Hui; P Otto; P Gupta; H Farzadegan
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

7.  Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens.

Authors:  V Gouvea; R I Glass; P Woods; K Taniguchi; H F Clark; B Forrester; Z Y Fang
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

Review 8.  Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection.

Authors:  M Clementi; S Menzo; P Bagnarelli; A Valenza; S Paolucci; R Sampaolesi; A Manzin; P E Varaldo
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

9.  Selective amplification of RNA utilizing the nucleotide analog dITP and Thermus thermophilus DNA polymerase.

Authors:  T Auer; J J Sninsky; D H Gelfand; T W Myers
Journal:  Nucleic Acids Res       Date:  1996-12-15       Impact factor: 16.971

10.  Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers.

Authors:  P Simmonds; P Balfe; J F Peutherer; C A Ludlam; J O Bishop; A J Brown
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.